← Back to Search

Emotional Awareness and Expression Therapy for Migraine (EAET Trial)

Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of either episodic or chronic migraine (with or without aura) by a licensed neurologist
Migraine disability assessment scores higher than 6
Screening 3 weeks
Treatment Varies
Follow Up 1 month before the treatment.
Awards & highlights

EAET Trial Summary

This trial tests a new intervention to see if it can help people with migraines by reducing frequency and severity. Participants take 8 online sessions, answer q's before/after, and benefit at no cost.

Who is the study for?
This trial is for adults aged 18-80 with a neurologist's diagnosis of episodic or chronic migraine. They must have had migraines for at least a year, experience them at least four days per month, and have been on stable medication for three months. People with serious psychiatric disorders, recent changes in migraine meds, or involvement in other treatment studies cannot join.Check my eligibility
What is being tested?
The study examines Emotional Awareness and Expression Therapy (EAET) to see if it can reduce the frequency and severity of migraines. Participants will be randomly placed into two groups: one receiving EAET through weekly online sessions and another as a control group that may receive treatment later.See study design
What are the potential side effects?
Since EAET is a behavioral intervention involving therapy sessions rather than medication, side effects are not typical but could include emotional discomfort due to discussing personal feelings related to pain during the therapy.

EAET Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I have been diagnosed with migraine by a neurologist.
My migraines significantly impact my daily life.
I experience at least 4 migraine days each month.

EAET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month before the treatment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month before the treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the number of migraine days in a month after treatment compared to baseline.
Number of migraine days in a month at baseline.
Secondary outcome measures
Allodynia levels at baseline.
Anxiety levels at baseline.
Change in allodynia after treatment compared to baseline.
+9 more

EAET Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Emotional Awareness and Expression Therapy (EAET)Experimental Treatment1 Intervention
In this experimental arm, participants are required to attend 8 online sessions and fill out questionnaires before treatment, and immediately after treatment.
Group II: Wait list controlActive Control1 Intervention
In this control arm, participants are required to wait 8 weeks until the treatment arm is completed and fill out questionnaires before and after the treatment date.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,095 Previous Clinical Trials
1,775,555 Total Patients Enrolled
1 Trials studying Migraine
109 Patients Enrolled for Migraine
Wayne State UniversityOTHER
307 Previous Clinical Trials
108,434 Total Patients Enrolled

Media Library

Emotional Awareness and Expression Therapy (EAET) Clinical Trial Eligibility Overview. Trial Name: NCT05837650 — N/A
Migraine Research Study Groups: Emotional Awareness and Expression Therapy (EAET), Wait list control
Migraine Clinical Trial 2023: Emotional Awareness and Expression Therapy (EAET) Highlights & Side Effects. Trial Name: NCT05837650 — N/A
Emotional Awareness and Expression Therapy (EAET) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05837650 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are joining this clinical trial?

"Correct. The official website for clinical trials confirms that this medical examination is presently recruiting participants, with the initial post being on April 1st 2023. This study requires 30 individuals to be recruited at one centre."

Answered by AI

Is there still time to sign up for this experiment?

"Indeed, the details on clinicaltrials.gov demonstrate that this medical experiment is actively recruiting participants. This trial was first posted April 1st 2023 and updated at the end of April 28th 2023; it requires 30 individuals from one site to participate."

Answered by AI

Does this research protocol include participants aged 35 and above?

"The terms of this trial allow patients aged 18-80 to participate. Furthermore, there are 36 studies for minors and 112 for senior citizens."

Answered by AI

Would I be able to join the study if I meet all of its requirements?

"The requirements for inclusion in this trial are simple: participants must suffer from migraines and fall within the 18-80 year old age range. 30 volunteers are being sought out to take part in this study."

Answered by AI

What objectives has this research endeavor set out to accomplish?

"This clinical trial is designed to track the alteration of patients' migraine days per month post-treatment, as well as changes in their quality of life and levels of allodynia. A questionnaire will be administered monthly over a period of one month before treatment commences for baseline data collection. The MSQL scores pre and post-intervention will evaluate the effectiveness at which it improves participants' wellbeing, while an Allodynia Questionnaire from 0 to 24 can gauge any reduction in symptoms such as burning or tingling sensations caused by stimuli that would normally not produce these responses."

Answered by AI

Who else is applying?

What site did they apply to?
Dan Kaufmann
What portion of applicants met pre-screening criteria?
Met criteria
~15 spots leftby Apr 2025